25 drug companies to phase out animal antibiotics

by Mary Clare Jalonick

The Food and Drug Administration says 25 pharmaceutical companies are voluntarily phasing out the use of antibiotics for growth promotion in animals processed for meat.

Citing a potential threat to , the agency in December asked 26 companies to voluntarily stop labeling drugs important for treating human infection as acceptable for use in animal production. The FDA did not name the one company that has not agreed to withdraw or revise its drugs.

The companies will either withdraw the drugs from animal use completely or revise them so they would only be able to be used with a veterinarian's prescription.

Many cattle, hog and give their animals antibiotics regularly to ensure that they are healthy and to make the animals grow faster.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA wants limits on antibiotics given to animals

Apr 11, 2012

(AP) -- The Food and Drug Administration called on drug companies Wednesday to help limit the use of antibiotics given to farm animals, a decades-old practice that scientists say has contributed to a surge in dangerous, ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

Physicians warned about counterfeit medical devices

Jul 24, 2014

(HealthDay)—Physicians should be aware of the prevalence and serious consequences associated with use of counterfeit medical devices, according to a letter to the editor published online July 20 in Lasers in ...

User comments